Heartflow, Inc. (NASDAQ:HTFL) Receives Consensus Rating of "Moderate Buy" from Brokerages

Key Points

• Analysts assign Heartflow a “Moderate Buy” consensus rating: Eight of 12 analysts rate the stock a buy, one rates it a strong buy, two recommend holding, and one recommends selling. The average 12-month price target is $43.43.
• Heartflow reported quarterly revenue of $64.08 million, up 47.7% year over year, and posted an adjusted loss of $0.07 per share—better than the $0.22 loss analysts expected. Despite the improvement, the company remains unprofitable, with a negative net margin of 55.82%.
• The stock opened at $41.94, near its 52-week high of $43.28, after trading well above its 50-day and 200-day moving averages. CEO John C.M. Farquhar sold 22,562 shares under a pre-arranged trading plan, while several institutional investors recently established or increased positions.

Heartflow, Inc. (NASDAQ:HTFL - Get Free Report) has earned a consensus rating of "Moderate Buy" from the twelve analysts that are presently covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating, eight have assigned a buy rating and one has given a strong buy rating to the company. The average 1 year target price among analysts that have issued a report on the stock in the last year is $43.4286.

Several research analysts have weighed in on the company. Robert W. Baird set a $45.00 price target on Heartflow in a research note on Friday. Morgan Stanley boosted their target price on shares of Heartflow from $35.00 to $40.00 and gave the stock an "equal weight" rating in a report on Friday. Stifel Nicolaus raised their target price on shares of Heartflow from $40.00 to $45.00 and gave the company a "buy" rating in a research note on Friday. Wells Fargo & Company lifted their price target on shares of Heartflow from $37.00 to $39.00 and gave the company an "overweight" rating in a report on Friday. Finally, Weiss Ratings upgraded shares of Heartflow from a "sell (e+)" rating to a "sell (d-)" rating in a research note on Friday, August 7th.

Insider Activity at Heartflow

In other Heartflow news, CEO John C.M. Farquhar sold 22,562 shares of the firm's stock in a transaction that occurred on Monday, August 10th. The stock was sold at an average price of $28.31, for a total transaction of $638,730.22. Following the completion of the transaction, the chief executive officer owned 436,280 shares in the company, valued at $12,351,086.80. This trade represents a 4.92% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 106,586 shares of company stock valued at $3,269,343 in the last quarter. 7.70% of the stock is currently owned by insiders.

Institutional Trading of Heartflow

Several hedge funds have recently made changes to their positions in the business. XXEC Inc. purchased a new position in shares of Heartflow in the 2nd quarter worth approximately $2,524,764,000. Wellington Management Group LLP boosted its stake in shares of Heartflow by 20.8% during the 4th quarter. Wellington Management Group LLP now owns 5,894,070 shares of the company's stock worth $171,812,000 after purchasing an additional 1,014,006 shares during the period. BlackRock Inc. purchased a new stake in Heartflow in the 2nd quarter worth about $152,502,000. Bamco Inc. NY bought a new stake in Heartflow in the second quarter worth about $94,625,000. Finally, Jupiter Topco LLC purchased a new position in shares of Heartflow during the second quarter valued at approximately $70,983,000.

Heartflow Stock Performance

HTFL opened at $41.94 on Tuesday. The firm's fifty day moving average is $29.35 and its 200 day moving average is $27.85. The stock has a market cap of $3.62 billion and a price-to-earnings ratio of -22.92. Heartflow has a fifty-two week low of $20.13 and a fifty-two week high of $43.28.

Heartflow (NASDAQ:HTFL - Get Free Report) last released its earnings results on Thursday, August 13th. The company reported ($0.07) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.22) by $0.15. The firm had revenue of $64.08 million during the quarter. Heartflow had a negative return on equity of 23.50% and a negative net margin of 55.82%.The company's quarterly revenue was up 47.7% compared to the same quarter last year. On average, equities research analysts predict that Heartflow will post -0.82 earnings per share for the current year.

Heartflow Company Profile

HeartFlow, Inc NASDAQ: HTFL is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company's core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow's analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow's cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source